Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cui-Tang is a concentrated traditional Chinese medicine (TCM) decoction developed by the Beijing Hospital of Traditional Chinese Medicine affiliated to Capital Medical University. It is a specialized hospital-made preparation (院内制剂) specifically formulated for the treatment of influenza and other viral respiratory infections. The 'Cui-Tang' formulation represents a modernized approach to traditional Chinese decoctions, utilizing advanced extraction and concentration techniques to produce a high-potency liquid form that is more convenient for patients than traditional bulk herbs. It is primarily used to alleviate symptoms such as fever, cough, and sore throat associated with influenza by modulating the immune response and exerting broad-spectrum anti-inflammatory and potentially antiviral effects. Within the hospital's clinical practice, it is a mainstay treatment in the fever clinic, particularly during seasonal influenza outbreaks.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Cui-Tang.